PL2727912T3 - Kryształy pochodnej glicyny i ich zastosowanie farmaceutyczne - Google Patents

Kryształy pochodnej glicyny i ich zastosowanie farmaceutyczne

Info

Publication number
PL2727912T3
PL2727912T3 PL12804465T PL12804465T PL2727912T3 PL 2727912 T3 PL2727912 T3 PL 2727912T3 PL 12804465 T PL12804465 T PL 12804465T PL 12804465 T PL12804465 T PL 12804465T PL 2727912 T3 PL2727912 T3 PL 2727912T3
Authority
PL
Poland
Prior art keywords
crystals
pharmaceutical use
glycine derivative
glycine
derivative
Prior art date
Application number
PL12804465T
Other languages
English (en)
Inventor
Motohiro Shiraki
Hirozumi Takahashi
Tsutomu Nogami
Original Assignee
Toray Industries, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries, Inc. filed Critical Toray Industries, Inc.
Publication of PL2727912T3 publication Critical patent/PL2727912T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL12804465T 2011-06-30 2012-06-29 Kryształy pochodnej glicyny i ich zastosowanie farmaceutyczne PL2727912T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2011145446 2011-06-30
PCT/JP2012/066672 WO2013002364A1 (ja) 2011-06-30 2012-06-29 グリシン誘導体の結晶及びその医薬用途
EP12804465.8A EP2727912B1 (en) 2011-06-30 2012-06-29 Crystals of glycine derivative and pharmaceutical use thereof

Publications (1)

Publication Number Publication Date
PL2727912T3 true PL2727912T3 (pl) 2017-12-29

Family

ID=47424249

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12804465T PL2727912T3 (pl) 2011-06-30 2012-06-29 Kryształy pochodnej glicyny i ich zastosowanie farmaceutyczne

Country Status (13)

Country Link
US (1) US9006434B2 (pl)
EP (1) EP2727912B1 (pl)
JP (1) JP5998933B2 (pl)
KR (1) KR20140027944A (pl)
CN (1) CN103619823B (pl)
AU (1) AU2012276650B2 (pl)
CA (1) CA2837453C (pl)
DK (1) DK2727912T3 (pl)
ES (1) ES2633179T3 (pl)
PL (1) PL2727912T3 (pl)
PT (1) PT2727912T (pl)
UA (1) UA111213C2 (pl)
WO (1) WO2013002364A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014051056A1 (ja) * 2012-09-28 2014-04-03 東レ株式会社 グリシン誘導体の結晶及びその医薬用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL63968A (en) 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
PL191496B1 (pl) * 1997-07-02 2006-05-31 Merck & Co Inc Odmiana polimorficzna 2-(R)-{1-(R) -[3,5-bis(trifluorometylo)-fenylo]etoksy} -3-(S)-(4-fluoro) fenylo-4-[3-(5-okso-1H,4H-1,2,4-triazolo)metylo] morfoliny, sposób jej wytwarzania, zawierająca ją kompozycja farmaceutyczna i jej zastosowanie
CN101128436B (zh) * 2004-12-24 2010-12-22 东丽株式会社 甘氨酸衍生物及其用途
CN101472580B (zh) * 2006-06-14 2011-08-24 东丽株式会社 过敏性皮炎的治疗或预防药
KR101423347B1 (ko) * 2006-06-19 2014-07-24 도레이 카부시키가이샤 다발성 경화증의 치료 또는 예방제
KR101353879B1 (ko) * 2006-06-20 2014-01-20 도레이 카부시키가이샤 백혈병의 치료 또는 예방제
WO2014051056A1 (ja) * 2012-09-28 2014-04-03 東レ株式会社 グリシン誘導体の結晶及びその医薬用途

Also Published As

Publication number Publication date
JPWO2013002364A1 (ja) 2015-02-23
ES2633179T3 (es) 2017-09-19
EP2727912A4 (en) 2014-12-10
CA2837453C (en) 2017-04-11
EP2727912A1 (en) 2014-05-07
EP2727912B1 (en) 2017-04-19
US9006434B2 (en) 2015-04-14
CN103619823B (zh) 2016-01-20
JP5998933B2 (ja) 2016-09-28
DK2727912T3 (en) 2017-07-17
PT2727912T (pt) 2017-07-25
KR20140027944A (ko) 2014-03-07
AU2012276650A1 (en) 2014-01-23
AU2012276650B2 (en) 2016-06-23
WO2013002364A1 (ja) 2013-01-03
CN103619823A (zh) 2014-03-05
CA2837453A1 (en) 2013-01-03
US20140128605A1 (en) 2014-05-08
UA111213C2 (uk) 2016-04-11

Similar Documents

Publication Publication Date Title
AU2012248676B2 (en) Peptide for inducing regeneration of tissue and use thereof
ZA201404962B (en) Modified mini-hepcidin peptides and methods of using thereof
IL228979A (en) A rich compound and a pharmacist's application for her
HUE044081T2 (hu) C4 Monometil-triterpenoid-származékok, és módszerek azok alkalmazására
AP2013007249A0 (en) Benzothiazole compounds and their pharmaceutical use
EP2739144A4 (en) COMPOUNDS AND ITS THERAPEUTIC USE
EP2788020A4 (en) THERAPEUTIC USE OF ANTI-CD22 ANTIBODIES FOR THE INDUCTION OF TROGO CYTOSIS
ZA201401653B (en) Pyrazol-4yl-heterocyclyl-carboxamide compounds and methods of use
ZA201401071B (en) Pyrazole compound and pharmaceutical use thereof
LT2706062T (lt) Naujas cefalosporino darinys ir jo farmacinė kompozicija
EP2709999A4 (en) CHINAZOLIN-7-ETHER COMPOUNDS AND ITS APPLICATION
PT2597084T (pt) Derivado de n-hidroxiformamida e medicamento contendo o mesmo
PT2727912T (pt) Cristais de derivado de glicina e seu uso farmacêutico
IL232809A (en) Carboxamides are preserved in position 2 isothiazolopyridine-2-carboxamides and used as drugs
PL2574343T3 (pl) Kompozycja do nanoszenia na skórę i zastosowanie tej kompozycji
GB201112578D0 (en) Pharmaceutical preparation and use
LT3199533T (lt) Pirazolo junginys ir jo farmacinis panaudojimas
HK1191950A (en) Indazole- and pyrrolopyridine-derivative and pharmaceutical use thereof
GB201104632D0 (en) Use of medicament